Advanced search

Mr. Øyvind Eriksen is a Chairman at Aker BP ASA, a President & Chief Executive Officer at Aker ASA, a Chairman at Aker Capital AS, a Chairman at Aker Horizons AS, a Chairman at Cognite AS, a Chairman at Rev Ocean AS, a Chairman at Rev Ocean, Inc. and an Executive Chairman at Aker Kvaerner Holding AS. He is on the Board of Directors at Aker Clean Hydrogen AS, The Resource Group TRG AS, Aker Solutions ASA, Aker Energy AS, Akastor ASA, Aker BioMarine AS, Aker Carbon Capture AS, Altus Intervention Group AS, Gluteus Medius AS, Kreftforeningen AS, Mainstream Renewable Power Ltd., Norwegian Cancer Society, Reitangruppen AS and TRG Holding AS. Mr. Eriksen was previously employed as a Chairman by Det norske oljeselskap ASA, a Chairman by BA-HR AS, and a Chairman by Aker Holding AS. He also served on the board at Havfisk AS and Aker Clean Carbon AS. He received his graduate degree from the University of Oslo.

Peter Bonne Eriksen is currently the Director at CytoVac AS since 2016.
Prior to this, he worked as the Senior Vice President-Regulatory Affairs at Novo Nordisk A.

Arne Stabell Eriksen has worked as a Director at CentraGruppen AS and Centra Invest AS.

Jan Eriksen worked as a Director at Dansk Spil A and Danske Spil A.